a retired major general is among 1,000 british service personnel requiring psychiatric treatment after taking an anti-malarial drug issued by the ministry of defence
new figures released by the ministry of defence show that since 2008 , 994 personnel have been treated for mental health issues after having been prescribed mefloquine
despite mefloquine - the brand name for the drug mefloquine - being banned by the u.s. military due to concerns over side effects , the ministry of defence has ignored appeals to stop prescribing it in what critics say is an escalating ' scandal '
major - general alastair duncan ( pictured ) is currently in a psychiatric unit after having been given the drug prior to a deployment in sierra leone according to the independent 's jonathan owen , retired major general alastair duncan is currently in a psychiatric unit following a post traumatic stress disorder episode four months ago
maj - gen alastair duncan was given the drug lariam before a deployment to sierra leone
general lord dannatt told the paper it was ' extraordinary ' the ministry of defence continued to prescribe mefloquine given the weight of evidence about its side effects , and urged it to use other anti-malaria medicines
in 2013 , the organisation gave it a ' boxed warning ' - the most serious of its kind - due to the neurological and psychiatric side effects associated with it
it stated : ' neurologic side effects can occur at any time during drug use , and can last for months to years after the drug is stopped or can be permanent
side effects include seizures , depression , hallucinations , violent behaviour , feeling that others want to harm you , thoughts of hurting or killing yourself and many others
the about - face followed years of complaints and concerns that mefloquine caused psychiatric and physical side effects